Global Drugs for Herpes Labialis (Oral Herpes) Market Research Report 2023

Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.

The global Drugs for Herpes Labialis (Oral Herpes) market was valued at US$ 2588.7 million in 2022 and is anticipated to reach US$ 3449.3 million by 2029, witnessing a CAGR of 4.9% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Drugs for Herpes Labialis (Oral Herpes) key players include GSK, Novartis, Teva, Mylan, Cadila, etc. Global top five manufacturers hold a share about 55%. North America is the largest market, with a share about 35%, followed by Europe, with a share about 30 percent. In terms of product, Rx Drugs is the largest segment, with a share about 90%. And in terms of application, the largest application is Oral, followed by External Use, and Injection, etc.

This report aims to provide a comprehensive presentation of the global market for Drugs for Herpes Labialis (Oral Herpes), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Herpes Labialis (Oral Herpes).

The Drugs for Herpes Labialis (Oral Herpes) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Drugs for Herpes Labialis (Oral Herpes) market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drugs for Herpes Labialis (Oral Herpes) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Aciclovir

1.2.3 Valacyclovir

1.2.4 Famciclovir

1.2.5 Docosanol

1.2.6 Other

1.3 Market by Application

1.3.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 External Use

1.3.3 Oral

1.3.4 Injection

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Perspective (2018-2029)

2.2 Drugs for Herpes Labialis (Oral Herpes) Growth Trends by Region

2.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Drugs for Herpes Labialis (Oral Herpes) Historic Market Size by Region (2018-2023)

2.2.3 Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Region (2024-2029)

2.3 Drugs for Herpes Labialis (Oral Herpes) Market Dynamics

2.3.1 Drugs for Herpes Labialis (Oral Herpes) Industry Trends

2.3.2 Drugs for Herpes Labialis (Oral Herpes) Market Drivers

2.3.3 Drugs for Herpes Labialis (Oral Herpes) Market Challenges

2.3.4 Drugs for Herpes Labialis (Oral Herpes) Market Restraints

3.1 Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Revenue

3.1.1 Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Revenue (2018-2023)

3.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Players (2018-2023)

3.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Drugs for Herpes Labialis (Oral Herpes) Revenue

3.4 Global Drugs for Herpes Labialis (Oral Herpes) Market Concentration Ratio

3.4.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drugs for Herpes Labialis (Oral Herpes) Revenue in 2022

3.5 Drugs for Herpes Labialis (Oral Herpes) Key Players Head office and Area Served

3.6 Key Players Drugs for Herpes Labialis (Oral Herpes) Product Solution and Service

3.7 Date of Enter into Drugs for Herpes Labialis (Oral Herpes) Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size by Type (2018-2023)

4.2 Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Type (2024-2029)

5.1 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size by Application (2018-2023)

5.2 Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Application (2024-2029)

6.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size (2018-2029)

6.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2018-2023)

6.4 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size (2018-2029)

7.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2018-2023)

7.4 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size (2018-2029)

8.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2018-2023)

8.4 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size (2018-2029)

9.2 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2018-2023)

9.4 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size (2018-2029)

10.2 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2018-2023)

10.4 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 GSK

11.1.1 GSK Company Detail

11.1.2 GSK Business Overview

11.1.3 GSK Drugs for Herpes Labialis (Oral Herpes) Introduction

11.1.4 GSK Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

11.1.5 GSK Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Drugs for Herpes Labialis (Oral Herpes) Introduction

11.2.4 Novartis Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

11.2.5 Novartis Recent Development

11.3 Teva

11.3.1 Teva Company Detail

11.3.2 Teva Business Overview

11.3.3 Teva Drugs for Herpes Labialis (Oral Herpes) Introduction

11.3.4 Teva Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

11.3.5 Teva Recent Development

11.4 Mylan

11.4.1 Mylan Company Detail

11.4.2 Mylan Business Overview

11.4.3 Mylan Drugs for Herpes Labialis (Oral Herpes) Introduction

11.4.4 Mylan Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

11.4.5 Mylan Recent Development

11.5 Cadila

11.5.1 Cadila Company Detail

11.5.2 Cadila Business Overview

11.5.3 Cadila Drugs for Herpes Labialis (Oral Herpes) Introduction

11.5.4 Cadila Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

11.5.5 Cadila Recent Development

11.6 Apotex

11.6.1 Apotex Company Detail

11.6.2 Apotex Business Overview

11.6.3 Apotex Drugs for Herpes Labialis (Oral Herpes) Introduction

11.6.4 Apotex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

11.6.5 Apotex Recent Development

11.7 Daewoong Pharmaceutical

11.7.1 Daewoong Pharmaceutical Company Detail

11.7.2 Daewoong Pharmaceutical Business Overview

11.7.3 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Introduction

11.7.4 Daewoong Pharmaceutical Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

11.7.5 Daewoong Pharmaceutical Recent Development

11.8 Livzon

11.8.1 Livzon Company Detail

11.8.2 Livzon Business Overview

11.8.3 Livzon Drugs for Herpes Labialis (Oral Herpes) Introduction

11.8.4 Livzon Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

11.8.5 Livzon Recent Development

11.9 Luoxin

11.9.1 Luoxin Company Detail

11.9.2 Luoxin Business Overview

11.9.3 Luoxin Drugs for Herpes Labialis (Oral Herpes) Introduction

11.9.4 Luoxin Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

11.9.5 Luoxin Recent Development

11.10 Med shine

11.10.1 Med shine Company Detail

11.10.2 Med shine Business Overview

11.10.3 Med shine Drugs for Herpes Labialis (Oral Herpes) Introduction

11.10.4 Med shine Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

11.10.5 Med shine Recent Development

11.11 Bayer (Campho Phenique)

11.11.1 Bayer (Campho Phenique) Company Detail

11.11.2 Bayer (Campho Phenique) Business Overview

11.11.3 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Introduction

11.11.4 Bayer (Campho Phenique) Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

11.11.5 Bayer (Campho Phenique) Recent Development

11.12 Blistex

11.12.1 Blistex Company Detail

11.12.2 Blistex Business Overview

11.12.3 Blistex Drugs for Herpes Labialis (Oral Herpes) Introduction

11.12.4 Blistex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

11.12.5 Blistex Recent Development

11.13 Kelun

11.13.1 Kelun Company Detail

11.13.2 Kelun Business Overview

11.13.3 Kelun Drugs for Herpes Labialis (Oral Herpes) Introduction

11.13.4 Kelun Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

11.13.5 Kelun Recent Development

11.14 Hikma

11.14.1 Hikma Company Detail

11.14.2 Hikma Business Overview

11.14.3 Hikma Drugs for Herpes Labialis (Oral Herpes) Introduction

11.14.4 Hikma Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

11.14.5 Hikma Recent Development

11.15 Haiwang

11.15.1 Haiwang Company Detail

11.15.2 Haiwang Business Overview

11.15.3 Haiwang Drugs for Herpes Labialis (Oral Herpes) Introduction

11.15.4 Haiwang Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

11.15.5 Haiwang Recent Development

11.16 Carmex

11.16.1 Carmex Company Detail

11.16.2 Carmex Business Overview

11.16.3 Carmex Drugs for Herpes Labialis (Oral Herpes) Introduction

11.16.4 Carmex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

11.16.5 Carmex Recent Development

11.17 Cipher

11.17.1 Cipher Company Detail

11.17.2 Cipher Business Overview

11.17.3 Cipher Drugs for Herpes Labialis (Oral Herpes) Introduction

11.17.4 Cipher Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

11.17.5 Cipher Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Aciclovir

    Table 3. Key Players of Valacyclovir

    Table 4. Key Players of Famciclovir

    Table 5. Key Players of Docosanol

    Table 6. Key Players of Other

    Table 7. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region (2018-2023)

    Table 11. Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region (2024-2029)

    Table 13. Drugs for Herpes Labialis (Oral Herpes) Market Trends

    Table 14. Drugs for Herpes Labialis (Oral Herpes) Market Drivers

    Table 15. Drugs for Herpes Labialis (Oral Herpes) Market Challenges

    Table 16. Drugs for Herpes Labialis (Oral Herpes) Market Restraints

    Table 17. Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Players (2018-2023)

    Table 19. Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Herpes Labialis (Oral Herpes) as of 2022)

    Table 20. Ranking of Global Top Drugs for Herpes Labialis (Oral Herpes) Companies by Revenue (US$ Million) in 2022

    Table 21. Global 5 Largest Players Market Share by Drugs for Herpes Labialis (Oral Herpes) Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players Drugs for Herpes Labialis (Oral Herpes) Product Solution and Service

    Table 24. Date of Enter into Drugs for Herpes Labialis (Oral Herpes) Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2018-2023)

    Table 28. Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2024-2029)

    Table 30. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2018-2023) & (US$ Million)

    Table 31. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Application (2018-2023)

    Table 32. Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 33. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Application (2024-2029)

    Table 34. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2018-2023) & (US$ Million)

    Table 36. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2018-2023) & (US$ Million)

    Table 39. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2018-2023) & (US$ Million)

    Table 42. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2024-2029) & (US$ Million)

    Table 43. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2024-2029) & (US$ Million)

    Table 49. GSK Company Detail

    Table 50. GSK Business Overview

    Table 51. GSK Drugs for Herpes Labialis (Oral Herpes) Product

    Table 52. GSK Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023) & (US$ Million)

    Table 53. GSK Recent Development

    Table 54. Novartis Company Detail

    Table 55. Novartis Business Overview

    Table 56. Novartis Drugs for Herpes Labialis (Oral Herpes) Product

    Table 57. Novartis Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023) & (US$ Million)

    Table 58. Novartis Recent Development

    Table 59. Teva Company Detail

    Table 60. Teva Business Overview

    Table 61. Teva Drugs for Herpes Labialis (Oral Herpes) Product

    Table 62. Teva Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023) & (US$ Million)

    Table 63. Teva Recent Development

    Table 64. Mylan Company Detail

    Table 65. Mylan Business Overview

    Table 66. Mylan Drugs for Herpes Labialis (Oral Herpes) Product

    Table 67. Mylan Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023) & (US$ Million)

    Table 68. Mylan Recent Development

    Table 69. Cadila Company Detail

    Table 70. Cadila Business Overview

    Table 71. Cadila Drugs for Herpes Labialis (Oral Herpes) Product

    Table 72. Cadila Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023) & (US$ Million)

    Table 73. Cadila Recent Development

    Table 74. Apotex Company Detail

    Table 75. Apotex Business Overview

    Table 76. Apotex Drugs for Herpes Labialis (Oral Herpes) Product

    Table 77. Apotex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023) & (US$ Million)

    Table 78. Apotex Recent Development

    Table 79. Daewoong Pharmaceutical Company Detail

    Table 80. Daewoong Pharmaceutical Business Overview

    Table 81. Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product

    Table 82. Daewoong Pharmaceutical Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023) & (US$ Million)

    Table 83. Daewoong Pharmaceutical Recent Development

    Table 84. Livzon Company Detail

    Table 85. Livzon Business Overview

    Table 86. Livzon Drugs for Herpes Labialis (Oral Herpes) Product

    Table 87. Livzon Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023) & (US$ Million)

    Table 88. Livzon Recent Development

    Table 89. Luoxin Company Detail

    Table 90. Luoxin Business Overview

    Table 91. Luoxin Drugs for Herpes Labialis (Oral Herpes) Product

    Table 92. Luoxin Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023) & (US$ Million)

    Table 93. Luoxin Recent Development

    Table 94. Med shine Company Detail

    Table 95. Med shine Business Overview

    Table 96. Med shine Drugs for Herpes Labialis (Oral Herpes) Product

    Table 97. Med shine Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023) & (US$ Million)

    Table 98. Med shine Recent Development

    Table 99. Bayer (Campho Phenique) Company Detail

    Table 100. Bayer (Campho Phenique) Business Overview

    Table 101. Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product

    Table 102. Bayer (Campho Phenique) Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023) & (US$ Million)

    Table 103. Bayer (Campho Phenique) Recent Development

    Table 104. Blistex Company Detail

    Table 105. Blistex Business Overview

    Table 106. Blistex Drugs for Herpes Labialis (Oral Herpes) Product

    Table 107. Blistex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023) & (US$ Million)

    Table 108. Blistex Recent Development

    Table 109. Kelun Company Detail

    Table 110. Kelun Business Overview

    Table 111. Kelun Drugs for Herpes Labialis (Oral Herpes) Product

    Table 112. Kelun Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023) & (US$ Million)

    Table 113. Kelun Recent Development

    Table 114. Hikma Company Detail

    Table 115. Hikma Business Overview

    Table 116. Hikma Drugs for Herpes Labialis (Oral Herpes) Product

    Table 117. Hikma Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023) & (US$ Million)

    Table 118. Hikma Recent Development

    Table 119. Haiwang Company Detail

    Table 120. Haiwang Business Overview

    Table 121. Haiwang Drugs for Herpes Labialis (Oral Herpes) Product

    Table 122. Haiwang Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023) & (US$ Million)

    Table 123. Haiwang Recent Development

    Table 124. Carmex Company Detail

    Table 125. Carmex Business Overview

    Table 126. Carmex Drugs for Herpes Labialis (Oral Herpes) Product

    Table 127. Carmex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023) & (US$ Million)

    Table 128. Carmex Recent Development

    Table 129. Cipher Company Detail

    Table 130. Cipher Business Overview

    Table 131. Cipher Drugs for Herpes Labialis (Oral Herpes) Product

    Table 132. Cipher Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023) & (US$ Million)

    Table 133. Cipher Recent Development

    Table 134. Research Programs/Design for This Report

    Table 135. Key Data Information from Secondary Sources

    Table 136. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Type: 2022 VS 2029

    Figure 3. Aciclovir Features

    Figure 4. Valacyclovir Features

    Figure 5. Famciclovir Features

    Figure 6. Docosanol Features

    Figure 7. Other Features

    Figure 8. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Application: 2022 VS 2029

    Figure 10. External Use Case Studies

    Figure 11. Oral Case Studies

    Figure 12. Injection Case Studies

    Figure 13. Drugs for Herpes Labialis (Oral Herpes) Report Years Considered

    Figure 14. Global Drugs for Herpes Labialis (Oral Herpes) Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Drugs for Herpes Labialis (Oral Herpes) Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region: 2022 VS 2029

    Figure 17. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Players in 2022

    Figure 18. Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Herpes Labialis (Oral Herpes) as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Drugs for Herpes Labialis (Oral Herpes) Revenue in 2022

    Figure 20. North America Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2018-2029)

    Figure 22. United States Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2018-2029)

    Figure 26. Germany Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Share by Region (2018-2029)

    Figure 34. China Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2018-2029)

    Figure 42. Mexico Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2018-2029)

    Figure 46. Turkey Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. GSK Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

    Figure 49. Novartis Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

    Figure 50. Teva Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

    Figure 51. Mylan Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

    Figure 52. Cadila Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

    Figure 53. Apotex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

    Figure 54. Daewoong Pharmaceutical Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

    Figure 55. Livzon Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

    Figure 56. Luoxin Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

    Figure 57. Med shine Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

    Figure 58. Bayer (Campho Phenique) Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

    Figure 59. Blistex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

    Figure 60. Kelun Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

    Figure 61. Hikma Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

    Figure 62. Haiwang Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

    Figure 63. Carmex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

    Figure 64. Cipher Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2018-2023)

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed